How Interferon Affects Cholesterol Production During Viral Infections
Author Information
Author(s): Mathieu Blanc, Wei Yuan Hsieh, Kevin A. Robertson, Steven Watterson, Guanghou Shui, Paul Lacaze, Mizanur Khondoker, Paul Dickinson, Garwin Sing, Sara Rodríguez-Martín, Peter Phelan, Thorsten Forster, Birgit Strobl, Matthias Müller, Rudolph Riemersma, Timothy Osborne, Markus R. Wenk, Ana Angulo, Peter Ghazal
Primary Institution: University of Edinburgh
Hypothesis
The study investigates the role of interferon in regulating cholesterol biosynthesis during viral infections.
Conclusion
The research demonstrates that type 1 interferon signaling is crucial for down-regulating the sterol metabolic network during viral infections, which may enhance antiviral defenses.
Supporting Evidence
- Interferon treatment leads to a significant reduction in cholesterol metabolite levels in infected cells.
- Genetic knockout of interferon receptors abolishes the down-regulation of the sterol biosynthesis pathway.
- Pharmacological inhibition of cholesterol synthesis enhances protection against viral infections.
- Type 1 interferon signaling is necessary for the transcriptional down-regulation of sterol biosynthesis genes.
Takeaway
When our body fights a virus, it uses a special signal called interferon that helps lower cholesterol production, which is important for stopping the virus from spreading.
Methodology
The study used time-series experiments to profile gene expression in macrophages infected with viruses and treated with interferon, along with lipidomic measurements to assess sterol metabolite levels.
Limitations
The study primarily focuses on specific viral infections and may not generalize to all types of infections or immune responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website